Here is some of the media coverage of MDS Pharma Services that has appeared recently in general business and trade media outlets. Wherever possible, we have provided links to the publication indicated.
February 2008
- Scrip World Pharma News (February) and Outsourcing Pharma (January) were two of many outlets to pick up our news release on the opening of our Global Clinical Development office in Sao Paulo, Brazil.
- In February, AOL Money & Finance and Outsourcing Pharma were among  the many outlets to cover the launch of Apollo, Global Central Lab’s proprietary trial management system.
- Flinn Foundation's Biosciences online newsletter, which focuses on the Arizona biomedical research industry, includes an article on our new Phase I facility near Phoenix in its February issue: click here for full article.
January 2008
- Applied Clinical Trials featured our Beijing Central Lab expansion in its January 2008 edition.
- In January 2008, NewsRx, Bio Spectrum Asia, Pharma Business Week, Life Science Weekly, The Biloxi Sun Herald and OutSourcingPharma, among others, reported on the election of MDS Pharma Services President Dave Spaight, chair of the Association of Clinical Research Organizations (ACRO). Click here to read Dave Spaight's first commentary as ACRO Chair.
- PharmaLive included an article in January 2008 about the opening of our Phase I clinic in Tempe, Arizona, which more than triples our capacity in the Phoenix area. In addition to widespread pickup of the news release, news stories also appeared in January in the online publication Outsourcing Pharma and in the weekly and monthly versions of CenterWatch. Global Early Clinical Research Vice President and General Manager Riaz Bandali and Vice President, Clinical Operations Eric Valentine were interviewed for the CenterWatch item, as was Phoenix Clinical Site Director Phil Bach. Click here for the CenterWatch story.
December 2007
- Next Generation Pharmaceutical (Dec. 10, 2007) included an interview with MDS Pharma Services President Dave Spaight, in which he discussed the power of electronic solutions and Web-based applications for expediting various aspects of clinical trials, as well as some of the regulatory gaps that must be overcome to minimize risk and move the trial along. Read the full article here
- Next Generation Pharmaceutical (Dec. 10, 2007) also ran an article about the MDS Pharma Services brand promise to deliver quality results on time.
- In December, numerous publications and Web sites, including The Globe and Mail, MSN Money, and TradingMarkets.com covered the year-end financial results for MDS Inc., noting that MDS Pharma Services delivered its fifth consecutive quarter of sequential improvement in profitability, with $5 million of adjusted EBITDA, up $12 million from a loss of $7 million in the prior year.
- In an article entitled "MDS Pharma Services breaks even in Q4," PharmaTimes (December 17, 2007) noted the progress our business unit has made on its "climb back to financial health in the fourth quarter of 2007."
- Outsourcing Pharma (12-19-07) reported that MDS Pharma Services is continuing to move on from the trouble caused by a U.S. Food and Drug Administration (FDA) review." They also mentioned the recent growth of our Central Lab operation in Beijing, China, and the upcoming expansion of our Phase I site in Phoenix, Arizona.
November 2007
- PharmaLive and Stockhouse Canada noted in November that MDS Pharma Services is now a major sponsor of the Alex's Lemonade Stand Foundation and its work to fight childhood cancer. According to the U.S. National Institutes of Health, cancer is the second leading cause of childhood death after accidents in the United States.
- The launch of MDS Pharma Services’ new brand promise  to deliver high-quality services on time made headlines in November in Pharmaceutical Online, Canada NewsWire, Calibre, PharmaLive and Canada Stockwatch, among others. Pharmaceutical Online quoted MDS Pharma Services President Dave Spaight: "We recognize the importance of high-quality on-time delivery for clients in every phase of the drug discovery and development process. Our employees are committed to this brand promise as part of our global strategy to support our clients' success."
MDS Pharma Services In The News 2007 - Archive
|
| |
|
